[66] [68] Selumetinib [edit] Selumetinib is a drug produced by Astra Zeneca sold under the brand name Koselugo, and was approved by the FDA in April 2020 [69] for the treatment of NF-1 in the pediatric population who are two or more years of age
Moreover, many ADC programs still rely on single-threshold biomarker definitions (e.g., IHC 2 +/3 +) that fail to account for temporal and spatial variation in target expression, TME context, or drug penetration potential [259, 306, 307]
A third approach is the H-Wave device , which uses a special waveform designed to cause gentle, non-fatiguing muscle contractions
As a result of oxidation which is a natural process during the process of metabolism, the formation of free radicals, which cause various damages in the organism and initiator of some vital chronic diseases such as cancer and heart diseases, increased the interest in antioxidant compounds that combat them, and studies on this subject mostly focused on the determination of antioxidant activities
These targeted delivery systems ensure high curcumin concentration directly at the diseased site for extended periods, which is ideal for chronic periodontitis management ( 4.6 Toothpastes and chewing gums Curcumin has been included in some herbal toothpastes aimed at reducing plaque and gingivitis
Consistent with the cytotoxic assay, a significant increase in the apoptosis rate was detectable after 4 h of treatment and became more pronounced after 24 h, with a slight increase at 48 h
